Literature DB >> 20376511

Intermittent weekly administration of human parathyroid hormone (1-34) improves bone-hydroxyapatite block bonding in ovariectomized rats.

Keiji Kamo1, Naohisa Miyakoshi, Yuji Kasukawa, Koji Nozaka, Hiroshi Sasaki, Yoichi Shimada.   

Abstract

Hydroxyapatite (HA) blocks have been widely used for the reconstruction of bone defects and as a bone substitute. Bone-implant bonding depends on both implant-related factors and patient variables. Intermittent human parathyroid hormone (h-PTH) has a strong anabolic effect on bone formation. The purpose of the present study is to evaluate whether intermittent h-PTH administration enhances bone-HA block bonding in normal versus ovariectomized (OVX) rats. Cancellous bone osteotomy and HA-block implantation were performed on the proximal left tibia in both OVX and sham-operated 7-month-old female Sprague-Dawley rats. Newly formed cancellous bone around the HA block and bone-HA block bonding were evaluated by bone histomorphometry at 8 weeks after the administration of h-PTH (100 μg/kg/week) or its vehicle. The administration of h-PTH significantly increased cancellous bone volume by stimulating bone formation in OVX rats (p < 0.01). Although bone-HA block bonding was significantly decreased in OVX rats compared to that of sham-operated rats (p < 0.01), h-PTH improved the bone-HA block bonding in OVX rats (p < 0.01). These results suggest that intermittent h-PTH treatment may improve bone-HA bonding in osteoporosis by restoring cancellous bone volume and enhancing cancellous bone formation around the HA block.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20376511     DOI: 10.1007/s00774-010-0178-z

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  31 in total

1.  Evidence that anabolic effects of PTH on bone require IGF-I in growing mice.

Authors:  N Miyakoshi; Y Kasukawa; T A Linkhart; D J Baylink; S Mohan
Journal:  Endocrinology       Date:  2001-10       Impact factor: 4.736

2.  Comparison of the action of transient and continuous PTH on primary osteoblast cultures expressing differentiation stage-specific GFP.

Authors:  Yu-Hsiung Wang; Yaling Liu; Kathy Buhl; David W Rowe
Journal:  J Bone Miner Res       Date:  2004-10-25       Impact factor: 6.741

3.  Effects of a weekly injection of human parathyroid hormone (1-34) and withdrawal on bone mass, strength, and turnover in mature ovariectomized rats.

Authors:  N Okimoto; H Tsurukami; Y Okazaki; S Nishida; A Sakai; H Ohnishi; M Hori; K Yasukawa; T Nakamura
Journal:  Bone       Date:  1998-05       Impact factor: 4.398

4.  Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee.

Authors:  A M Parfitt; M K Drezner; F H Glorieux; J A Kanis; H Malluche; P J Meunier; S M Ott; R R Recker
Journal:  J Bone Miner Res       Date:  1987-12       Impact factor: 6.741

5.  Enhancement of experimental fracture-healing by systemic administration of recombinant human parathyroid hormone (PTH 1-34).

Authors:  Yaser M Alkhiary; Louis C Gerstenfeld; Elizabeth Krall; Michael Westmore; Masahiko Sato; Bruce H Mitlak; Thomas A Einhorn
Journal:  J Bone Joint Surg Am       Date:  2005-04       Impact factor: 5.284

6.  Parathyroid hormone regulates the expression of fibroblast growth factor-2 mRNA and fibroblast growth factor receptor mRNA in osteoblastic cells.

Authors:  M M Hurley; S Tetradis; Y F Huang; J Hock; B E Kream; L G Raisz; M G Sabbieti
Journal:  J Bone Miner Res       Date:  1999-05       Impact factor: 6.741

7.  Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis.

Authors:  R Lindsay; J Nieves; C Formica; E Henneman; L Woelfert; V Shen; D Dempster; F Cosman
Journal:  Lancet       Date:  1997-08-23       Impact factor: 79.321

8.  The effect of hydroxyapatite coating on the bonding of bone to titanium implants in the femora of ovariectomised rats.

Authors:  T Hara; K Hayashi; Y Nakashima; T Kanemaru; Y Iwamoto
Journal:  J Bone Joint Surg Br       Date:  1999-07

9.  Effect of preoperative combined treatment with alendronate and calcitriol on fixation of hydroxyapatite-coated implants in ovariectomized rats.

Authors:  Yoshinari Nakamura; Kazuo Hayashi; Samah Abu-Ali; Masatoshi Naito; Abbas Fotovati
Journal:  J Bone Joint Surg Am       Date:  2008-04       Impact factor: 5.284

Review 10.  Effects of parathyroid hormone on cancellous bone mass and structure in osteoporosis.

Authors:  Naohisa Miyakoshi
Journal:  Curr Pharm Des       Date:  2004       Impact factor: 3.116

View more
  2 in total

1.  The effects of PTH, loading and surgical insult on cancellous bone at the bone-implant interface in the rabbit.

Authors:  Anna Fahlgren; Xu Yang; Cesare Ciani; James A Ryan; Natalie Kelly; Frank C Ko; Marjolein C H van der Meulen; Mathias P G Bostrom
Journal:  Bone       Date:  2012-05-18       Impact factor: 4.398

2.  Effects of teriparatide on morphology of aortic calcification in aged hyperlipidemic mice.

Authors:  Jeffrey J Hsu; Jinxiu Lu; Soban Umar; Jason T Lee; Rajan P Kulkarni; Yichen Ding; Chih-Chiang Chang; Tzung K Hsiai; Akishige Hokugo; Ioannis Gkouveris; Sotirios Tetradis; Ichiro Nishimura; Linda L Demer; Yin Tintut
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-02-16       Impact factor: 4.733

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.